KD Logo

Investing in Equifax, Inc (EFX) Is Getting More Attractive

Equifax, Inc’s recent filing unveils that its Officer GAMBLE JOHN W JR acquired Company’s shares for reported $0.85 million on Feb 28 ’25. In the deal valued at $242.31 per share,3,500 shares were bought.

Then, Begor Mark W sold 22,161 shares, generating $5,598,504 in total proceeds. Upon selling the shares at $252.63, the CEO now owns 142,243 shares.

Before that, Begor Mark W bought 22,161 shares. Equifax, Inc shares valued at $5,598,504 were divested by the Officer at a price of $252.63 per share.

Argus downgraded its Equifax, Inc [EFX] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Exane BNP Paribas’s analysts, who increased its forecast for the stock in mid December from “a Neutral” to “an Outperform”. Morgan Stanley also remained covering EFX and has increased its forecast on December 12, 2024 with a “an Overweight” recommendation from previously “an Equal-weight” rating. Wolfe Research revised its rating on December 12, 2024. It rated EFX as “a Peer perform” which previously was an “an Outperform”.

Price Performance Review of EFX

On Friday, Equifax, Inc [NYSE:EFX] saw its stock jump 1.06% to $245.20. Over the last five days, the stock has gained 3.01%. Equifax, Inc shares have fallen nearly -3.79% since the year began. Nevertheless, the stocks have fallen -8.62% over the past one year. While a 52-week high of $309.63 was reached on 01/27/25, a 52-week low of $213.02 was recorded on 02/21/25. SMA at 50 days reached $256.87, while 200 days put it at $265.46.

Levels Of Support And Resistance For EFX Stock

The 24-hour chart illustrates a support level at 241.88, which if violated will result in even more drops to 238.57. On the upside, there is a resistance level at 246.94. A further resistance level may holdings at 248.69. The Relative Strength Index (RSI) on the 14-day chart is 42.60, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.36, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 52.56%. Stochastics %K at 39.92% indicates the stock is a holding.

The most recent change occurred on October 01, 2024 when UBS began covering the stock and recommended ‘”a Buy”‘ rating along with a $360 price target.

Most Popular